The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens

NCT04242875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-03-17

Study results available
· View outcomes & findings →

Summary

Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case. This study was designed to investigate correlations between angle kappa and post-surgical outcomes with a trifocal IOL.

Conditions

  • Pseudophakia

Interventions

DIAGNOSTIC_TEST

Angle Kappa

Angle kappa will be measured using the OPD III scan.

OTHER

Visual disturbance questionnaire.

Questionnaire evaluating visual disturbances.

Sponsors & Collaborators

  • Science in Vision

    collaborator OTHER
  • Carolina Eyecare Physicians, LLC

    lead OTHER

Principal Investigators

  • Kerry Solomon · Carolina Eyecare Physicians

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2021-04-27
Completion
2021-04-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242875 on ClinicalTrials.gov